Dr. Rupali Nabar

Claim this profile

UC Irvine Health/Chao Family Comprehensive Cancer Center

Studies Squamous Cell Carcinoma
Studies Head and Neck Squamous Cell Carcinoma
4 reported clinical trials
13 drugs studied

Area of expertise

1

Squamous Cell Carcinoma

Rupali Nabar has run 2 trials for Squamous Cell Carcinoma. Some of their research focus areas include:

HPV positive
p16 negative
EGFR positive
2

Head And Neck Squamous Cell Carcinoma

Rupali Nabar has run 1 trial for Head and Neck Squamous Cell Carcinoma. Some of their research focus areas include:

HPV positive

Affiliated Hospitals

Image of trial facility.

UC Irvine Health/Chao Family Comprehensive Cancer Center

Image of trial facility.

UCI Health - Chao Family Comprehensive Cancer Center

Clinical Trials Rupali Nabar is currently running

Image of trial facility.

Chemotherapy + Radiation Therapy

for Head and Neck Cancer

This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, and/or atezolizumab after surgery in treating patients with high-risk stage III-IV head and neck cancer the begins in the thin, flat cells (squamous cell). Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Cetuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The purpose of this study is to compare the usual treatment (radiation therapy with cisplatin chemotherapy) to using radiation therapy with docetaxel and cetuximab chemotherapy, and using the usual treatment plus an immunotherapy drug, atezolizumab.

Recruiting

1 award

Phase 2 & 3

21 criteria

Image of trial facility.

AHCC Capsules

for Head and Neck Cancer

This is a phase 2, single-arm, open-label clinical trial determining safety and tolerability of AHCC in subjects with HPV-positive patients with Head and Neck Squamous Cell Carcinoma. These are subjects who have undergone surgery or will be undergoing surgery.

Recruiting

1 award

Phase 2

2 criteria

More about Rupali Nabar

Clinical Trial Related

12 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical Trials

Treatments Rupali Nabar has experience with

  • Cisplatin
  • Intensity-Modulated Radiation Therapy
  • AHCC
  • Fluorouracil
  • Gemcitabine Hydrochloride
  • Paclitaxel

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Rupali Nabar specialize in?

Is Rupali Nabar currently recruiting for clinical trials?

Are there any treatments that Rupali Nabar has studied deeply?

What is the best way to schedule an appointment with Rupali Nabar?

What is the office address of Rupali Nabar?

Is there any support for travel costs?